Comparison of lenograstim and filgrastim: effects on blood cell recovery after high-dose chemotherapy and autologous peripheral blood stem cell transplantation

Abstract

The aim of the study was to evaluate whether glycosylated granulocyte colony-stimulating factor (G-CSF) (lenograstim) offers a benefit over non-glycosylated G-CSF (filgrastim) in clinically relevant end points after high-dose chemotherapy (HDC) and autologous peripheral blood stem cell transplantation (PBSCT). We retrospectively analyzed the outcome of 261… (More)
DOI: 10.1007/s00432-004-0636-x

Topics

1 Figure or Table

Cite this paper

@article{Httmann2004ComparisonOL, title={Comparison of lenograstim and filgrastim: effects on blood cell recovery after high-dose chemotherapy and autologous peripheral blood stem cell transplantation}, author={Andreas H{\"u}ttmann and K. Schirsafi and Sigfried Seeber and Peter Bojko}, journal={Journal of Cancer Research and Clinical Oncology}, year={2004}, volume={131}, pages={152-156} }